Galera Therapeutics (GRTX) Short Interest Ratio & Short Volume $0.02 0.00 (-8.88%) As of 06/4/2025 03:39 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Galera Therapeutics Short Interest DataGalera Therapeutics (GRTX) has a short interest of 7,400 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 103,159 shares to cover all short positions.Current Short Interest7,400 sharesPrevious Short Interest7,400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$177.60Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2025Outstanding Shares75,462,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume64,285 sharesAverage Trading Volume103,159 sharesToday's Volume Vs. Average62% Short Selling Galera Therapeutics? Sign up to receive the latest short interest report for Galera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGRTX Short Interest Over TimeGRTX Days to Cover Over TimeGRTX Percentage of Float Shorted Over Time Galera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20257,400 shares $177.60 No ChangeN/A0.1 $0.02 4/30/20257,400 shares $163.54 No ChangeN/A0.1 $0.02 4/15/20257,400 shares $199.80 No ChangeN/A0 $0.03 3/14/20257,400 shares $251.60 No ChangeN/A0.1 $0.03 2/28/20257,400 shares $283.42 -3.9%N/A0.1 $0.04 2/14/20257,700 shares $323.40 -79.0%N/A0 $0.04 1/31/202536,600 shares $1,559.16 -3.2%N/A0.4 $0.04 1/15/202537,800 shares $1,742.58 +410.8%N/A0 $0.05 5/31/20241,910,000 shares $410,841.00 -9.9%5.5%1.1 $0.22 5/15/20242,120,000 shares $402,800.00 -24.0%6.1%1 $0.19 Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/30/20242,790,000 shares $519,777.00 +4.9%7.3%1.4 $0.19 4/15/20242,660,000 shares $406,714.00 +50.3%6.5%1.4 $0.15 3/31/20241,770,000 shares $247,800.00 -36.8%4.1%0.7 $0.14 3/15/20242,800,000 shares $591,360.00 -45.0%7.3%1.4 $0.21 2/29/20245,090,000 shares $1.24 million +51.5%13.3%2.5 $0.24 2/15/20243,360,000 shares $613,200.00 -4.0%8.6%1.7 $0.18 1/31/20243,500,000 shares $626,500.00 -24.6%9.9%1.9 $0.18 1/15/20244,640,000 shares $997,600.00 +197.4%13.1%1.4 $0.22 12/31/20231,560,000 shares $226,824.00 +12.2%3.7%0.4 $0.15 12/15/20231,390,000 shares $190,430.00 +1.5%3.3%0.4 $0.14 11/30/20231,370,000 shares $195,225.00 -24.7%3.5%0.3 $0.14 11/15/20231,820,000 shares $263,172.00 -36.6%4.5%0.4 $0.14 10/31/20232,870,000 shares $278,677.00 -1.0%8.0%0.5 $0.10 10/15/20232,900,000 shares $553,900.00 -18.3%8.1%0.6 $0.19 9/30/20233,550,000 shares $621,605.00 +73.2%9.9%1 $0.18 9/15/20232,050,000 shares $386,630.00 -15.6%5.7%0.6 $0.19 8/31/20232,430,000 shares $510,300.00 -27.7%6.8%1 $0.21 8/15/20233,360,000 shares $906,864.00 +128.6%9.4%1.4 $0.27 7/31/20231,470,000 shares $3.62 million +32.4%4.2%1.7 $2.46 7/15/20231,110,000 shares $3.05 million +12.8%3.2%1.6 $2.75 6/30/2023984,000 shares $3.07 million +11.8%2.9%1.6 $3.12 6/15/2023880,500 shares $2.98 million +8.4%2.6%1.4 $3.39 5/31/2023812,600 shares $2.49 million -1.7%2.4%1.2 $3.07 5/15/2023826,900 shares $2.63 million No Change2.4%1.1 $3.18 10/31/2022610,400 shares $885,080.00 +17.4%3.4%5 $1.45 10/15/2022519,800 shares $805,690.00 -2.5%2.9%6 $1.55 9/30/2022533,100 shares $927,594.00 +4.5%2.9%6.1 $1.74 9/15/2022510,200 shares $954,074.00 +8.5%2.8%5.4 $1.87 8/31/2022470,100 shares $629,934.00 +2.0%2.6%5.1 $1.34 8/15/2022460,900 shares $672,914.00 -4.9%2.5%5.5 $1.46The DOJ Just Paved the Way for Account Seizures (Ad)Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.Get your free guide now by clicking here >> 7/31/2022484,800 shares $562,368.00 -0.6%2.7%4.7 $1.16 7/15/2022487,900 shares $585,480.00 -8.7%2.7%3.7 $1.20 6/30/2022534,400 shares $694,720.00 -4.0%3.0%3.8 $1.30 6/15/2022556,700 shares $823,916.00 -6.2%3.1%3.8 $1.48 5/31/2022593,500 shares $949,600.00 +11.4%3.3%3.3 $1.60 5/15/2022533,000 shares $804,830.00 -17.5%2.9%2.4 $1.51 4/30/2022645,900 shares $1.09 million +21.0%3.6%2.6 $1.69 4/15/2022534,000 shares $1.14 million +1.9%3.0%1.7 $2.13 3/31/2022524,200 shares $1.25 million -8.0%N/A0 $2.38 3/15/2022569,800 shares $1.20 million -11.1%3.2%0.2 $2.10 2/28/2022640,700 shares $1.44 million +115.7%3.6%0.1 $2.24 2/15/2022297,000 shares $694,980.00 +93.7%1.7%0 $2.34 1/31/2022153,300 shares $420,042.00 -73.6%1.4%0 $2.74 1/15/2022580,700 shares $2.00 million -71.0%N/A0 $3.44 12/31/20212,000,000 shares $9.18 million +226.7%18.0%0.2 $4.59 12/15/2021612,100 shares $1.78 million -17.2%5.5%0.1 $2.90 11/30/2021739,100 shares $975,612.00 +14.6%7.1%0.2 $1.32 11/15/2021645,000 shares $1.08 million -57.6%6.2%0.2 $1.68 10/29/20211,520,000 shares $2.84 million +814.0%15.2%0.6 $1.87 10/15/2021166,300 shares $1.30 million +8.5%1.7%0.2 $7.81 9/30/2021153,300 shares $1.24 million -3.1%1.5%2.2 $8.10 9/15/2021158,200 shares $1.14 million -11.9%1.5%1.7 $7.18 8/31/2021179,600 shares $1.61 million -4.5%1.7%1.6 $8.96 8/13/2021188,100 shares $1.56 million -16.1%1.8%1.5 $8.30 7/30/2021224,200 shares $1.88 million -15.6%2.1%1.5 $8.38 7/15/2021265,600 shares $2.48 million -3.6%2.5%0.4 $9.34 6/30/2021275,500 shares $2.71 million -43.9%2.6%0.4 $9.83 6/15/2021490,900 shares $4.40 million +0.9%4.7%0.8 $8.96 5/28/2021486,600 shares $4.17 million -1.5%4.6%0.8 $8.57 5/14/2021494,000 shares $3.52 million +51.2%4.8%0.9 $7.12 4/30/2021326,700 shares $2.65 million +103.4%3.4%0.6 $8.12 4/15/2021160,600 shares $1.21 million +4.8%N/A0 $7.52 3/31/2021153,200 shares $1.28 million +6.0%1.6%2.3 $8.35 3/15/2021144,500 shares $1.59 million -2.0%1.5%2.2 $11.00 2/26/2021147,500 shares $1.55 million +13.5%1.5%2.1 $10.48 2/12/2021130,000 shares $1.54 million +12.9%1.3%1.9 $11.84 1/29/2021115,200 shares $1.22 million +25.6%1.4%1.7 $10.63 1/15/202191,700 shares $917,917.00 -18.7%1.1%1 $10.01 12/31/2020112,800 shares $1.22 million -5.7%1.4%1.5 $10.79 12/15/2020119,600 shares $1.29 million -1.0%1.4%1.3 $10.80 11/30/2020120,800 shares $1.35 million -10.8%1.5%1.5 $11.21 11/15/2020135,400 shares $1.38 million -4.1%1.6%1.8 $10.20 10/30/2020141,200 shares $1.24 million +63.8%1.7%2 $8.78 10/15/202086,200 shares $1.08 million -6.6%0.9%1.4 $12.50 9/30/202092,300 shares $834,392.00 -11.0%1.0%2.2 $9.04 9/15/2020103,700 shares $852,414.00 -8.2%1.1%2.5 $8.22 8/31/2020112,900 shares $881,749.00 -2.0%1.2%1.7 $7.81 8/14/2020115,200 shares $899,712.00 -1.5%1.2%1.6 $7.81 7/31/2020116,900 shares $813,624.00 -7.8%1.2%1.6 $6.96 7/15/2020126,800 shares $997,916.00 +4.4%1.3%1.8 $7.87Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged. 6/30/2020121,500 shares $982,935.00 -11.5%1.3%1.8 $8.09 6/15/2020137,300 shares $1.20 million +981.1%1.6%3 $8.72 GRTX Short Interest - Frequently Asked Questions What is Galera Therapeutics' current short interest? Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 7,400 shares of GRTX short. Learn More on Galera Therapeutics' current short interest. How does Galera Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Galera Therapeutics: Traws Pharma, Inc. (1.65%), Mainz Biomed (2.66%), Avalon GloboCare Corp. (3.30%), PharmaCyte Biotech, Inc. (0.06%), Omega Therapeutics, Inc. (26.99%), Citius Pharmaceuticals, Inc. (6.22%), Cardio Diagnostics Holdings, Inc. (3.48%), Pasithea Therapeutics Corp. (8.00%), NLS Pharmaceutics Ltd. (1.74%), Sunshine Biopharma, Inc. (6.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Galera Therapeutics stock? Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. GRTX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galera Therapeutics? A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further. How often is Galera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies TRAW Short Interest MYNZ Short Interest ALBT Short Interest PMCB Short Interest OMGA Short Interest CTXR Short Interest CDIO Short Interest KTTA Short Interest NLSP Short Interest SBFM Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRTX) was last updated on 6/5/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRTX Stock Free GRTX Stock Alerts